A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

NCT01969682 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped This study will be conducted in healthy volunteer subjects.

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: ABT-199
DRUG: Rifampin

Sponsor

AbbVie

Collaborators

[object Object]